Atia Gohar, Richard L Atkinson, Darakhshan J Haleem, Khaled Fahmi Fawy, Muhammad Shakeel
{"title":"天然蜂蜜蛋白质可预防饮食引起的大鼠肥胖和代谢紊乱。","authors":"Atia Gohar, Richard L Atkinson, Darakhshan J Haleem, Khaled Fahmi Fawy, Muhammad Shakeel","doi":"10.1089/jmf.2024.k.0093","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies have shown that oral whole honey reduces weight gain in rats on a normal diet (ND) or high-fat diet (HFD) and suppresses inflammation by modulating immunological cytokines in human neutrophils and macrophages. We hypothesize that the honey proteins (HP) are responsible for the reduced weight gain in rats on ND and HFD and that HP would alleviate obesity parameters. To test this, proteins were isolated from acacia honey through the salting-out method. Wistar rats (<i>N</i> = 24) were randomized to get ND or HFD for 4 weeks, then further randomized to four groups and treated with HP or saline for another 4 weeks. Energy intake (EI), body weight gain, EI per gram body weight gain, serum glucose, and lipids were measured. Expression of adipose tissue genes fatty acid binding protein (FABP), lipase C (LIPC), and apolipoprotein A-1 (APOA1) was evaluated through the quantitative polymerase chain reaction. HFD increased the body weight versus ND in weeks 1-4. HP for the next 4 weeks reduced weight gain in ND-HP and HFD-HP groups versus saline controls (<i>P</i> < .01). EI was not significantly different among groups. However, EI per gram body weight gain among groups was markedly different (<i>P</i> < .01), demonstrating reduced weight gain efficiency by HP (<i>P</i> < .01). HP reduced glucose in ND but not in HFD groups. Triglycerides were lower in both HP groups. The expressions of FABP, LIPC, and APOA1 genes were significantly increased (<i>P</i> < .05) in HP-treated HFD rats. Collectively, weight gain efficiency was remarkably reduced without altering EI in rats following the HP treatment, suggesting HP increased metabolic rate or substrate partitioning. Studies of HP are suggested in humans.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"68-74"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Natural Honey Proteins Prevent Diet-Induced Obesity and Metabolic Disorders in Rats.\",\"authors\":\"Atia Gohar, Richard L Atkinson, Darakhshan J Haleem, Khaled Fahmi Fawy, Muhammad Shakeel\",\"doi\":\"10.1089/jmf.2024.k.0093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Previous studies have shown that oral whole honey reduces weight gain in rats on a normal diet (ND) or high-fat diet (HFD) and suppresses inflammation by modulating immunological cytokines in human neutrophils and macrophages. We hypothesize that the honey proteins (HP) are responsible for the reduced weight gain in rats on ND and HFD and that HP would alleviate obesity parameters. To test this, proteins were isolated from acacia honey through the salting-out method. Wistar rats (<i>N</i> = 24) were randomized to get ND or HFD for 4 weeks, then further randomized to four groups and treated with HP or saline for another 4 weeks. Energy intake (EI), body weight gain, EI per gram body weight gain, serum glucose, and lipids were measured. Expression of adipose tissue genes fatty acid binding protein (FABP), lipase C (LIPC), and apolipoprotein A-1 (APOA1) was evaluated through the quantitative polymerase chain reaction. HFD increased the body weight versus ND in weeks 1-4. HP for the next 4 weeks reduced weight gain in ND-HP and HFD-HP groups versus saline controls (<i>P</i> < .01). EI was not significantly different among groups. However, EI per gram body weight gain among groups was markedly different (<i>P</i> < .01), demonstrating reduced weight gain efficiency by HP (<i>P</i> < .01). HP reduced glucose in ND but not in HFD groups. Triglycerides were lower in both HP groups. The expressions of FABP, LIPC, and APOA1 genes were significantly increased (<i>P</i> < .05) in HP-treated HFD rats. Collectively, weight gain efficiency was remarkably reduced without altering EI in rats following the HP treatment, suggesting HP increased metabolic rate or substrate partitioning. Studies of HP are suggested in humans.</p>\",\"PeriodicalId\":16440,\"journal\":{\"name\":\"Journal of medicinal food\",\"volume\":\" \",\"pages\":\"68-74\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medicinal food\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1089/jmf.2024.k.0093\",\"RegionNum\":3,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medicinal food","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1089/jmf.2024.k.0093","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
先前的研究表明,口服全蜂蜜可减少正常饮食(ND)或高脂饮食(HFD)大鼠的体重增加,并通过调节人中性粒细胞和巨噬细胞中的免疫细胞因子抑制炎症。我们假设蜂蜜蛋白质(HP)是导致 ND 和 HFD 大鼠体重增加减少的原因,并且 HP 会减轻肥胖参数。为了验证这一假设,我们通过盐析法从洋槐蜂蜜中分离出了蛋白质。Wistar 大鼠(N = 24)被随机分配到 ND 或 HFD 组 4 周,然后进一步随机分配到 4 个组,再用 HP 或生理盐水处理 4 周。测量能量摄入量(EI)、体重增加、每克体重增加的能量摄入量、血清葡萄糖和血脂。通过定量聚合酶链反应评估了脂肪组织基因脂肪酸结合蛋白(FABP)、脂肪酶 C(LIPC)和脂蛋白 A-1(APOA1)的表达。与 ND 相比,HFD 在第 1-4 周增加了体重。与生理盐水对照组相比,HP 在接下来的 4 周减少了 ND-HP 组和 HFD-HP 组的体重增加(P < .01)。各组间的 EI 无明显差异。但是,各组间每克体重增加的 EI 有明显差异(P < .01),这表明 HP 降低了体重增加效率(P < .01)。HP 能降低 ND 组的血糖,但不能降低 HFD 组的血糖。两个 HP 组的甘油三酯都较低。经 HP 处理的 HFD 大鼠 FABP、LIPC 和 APOA1 基因的表达量显著增加(P < .05)。总之,在 HP 处理后,大鼠的体重增加效率明显降低,但 EI 没有改变,这表明 HP 提高了代谢率或底物分配。建议对人类进行 HP 研究。
Natural Honey Proteins Prevent Diet-Induced Obesity and Metabolic Disorders in Rats.
Previous studies have shown that oral whole honey reduces weight gain in rats on a normal diet (ND) or high-fat diet (HFD) and suppresses inflammation by modulating immunological cytokines in human neutrophils and macrophages. We hypothesize that the honey proteins (HP) are responsible for the reduced weight gain in rats on ND and HFD and that HP would alleviate obesity parameters. To test this, proteins were isolated from acacia honey through the salting-out method. Wistar rats (N = 24) were randomized to get ND or HFD for 4 weeks, then further randomized to four groups and treated with HP or saline for another 4 weeks. Energy intake (EI), body weight gain, EI per gram body weight gain, serum glucose, and lipids were measured. Expression of adipose tissue genes fatty acid binding protein (FABP), lipase C (LIPC), and apolipoprotein A-1 (APOA1) was evaluated through the quantitative polymerase chain reaction. HFD increased the body weight versus ND in weeks 1-4. HP for the next 4 weeks reduced weight gain in ND-HP and HFD-HP groups versus saline controls (P < .01). EI was not significantly different among groups. However, EI per gram body weight gain among groups was markedly different (P < .01), demonstrating reduced weight gain efficiency by HP (P < .01). HP reduced glucose in ND but not in HFD groups. Triglycerides were lower in both HP groups. The expressions of FABP, LIPC, and APOA1 genes were significantly increased (P < .05) in HP-treated HFD rats. Collectively, weight gain efficiency was remarkably reduced without altering EI in rats following the HP treatment, suggesting HP increased metabolic rate or substrate partitioning. Studies of HP are suggested in humans.
期刊介绍:
Journal of Medicinal Food is the only peer-reviewed journal focusing exclusively on the medicinal value and biomedical effects of food materials. International in scope, the Journal advances the knowledge of the development of new food products and dietary supplements targeted at promoting health and the prevention and treatment of disease.